Guardant Health Inc at Cowen Health Care Conference Transcript
All right. Good morning, everyone, and welcome to day three of the Cowen Health Care Conference. For those of you who don't know me, I'm Doug Schenkel. I'm one of the healthcare analysts here at Cowen.
It's my pleasure to welcome you to this morning's presentation with Guardant Health. Guardant Health is the clear leader in liquid biopsy testing. The Company has done a fantastic job of amassing a very robust clinical dossier that has really led to a lot of success, both on the clinical side and also with a series of biopharmaceutical partners.
This is a very exciting year; the Company continues to make progress on both fronts. In a few weeks, we expect a lot of new data and catalysts at the AACR conference. Later this year, we have a series of expected clinical and regulatory catalysts, so there's lots to talk about, lots of excitement. And this is all coming off of a nice quarterly update last night.
So, with that all in mind, I'm going to hand it over to the Company's CEO, Helmy, who can tell the story much better than I can. Just
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
